Lucas is an accomplished clinical trial quality expert with nearly two decades of experience in Good Clinical Practice (GCP) across SMO and CRO environments. With a strong background in leadership and oversight, he has held senior responsibilities in Quality Assurance and Clinical Quality, ensuring that clinical trial activities meet high standards of regulatory compliance, patient safety and data integrity. quality management systems within the pharmaceutical industry. What gives me him unique perspective on this subject is his dual experience - having had the privilege of working both within the Polish Regulatory Authority and on the industry side, collaborating with organizations that plan and conduct clinical trials. This dual background allows him to understand the expectations of regulators while deeply appreciating the practical, day-to-day realities of trial operations.

His expertise includes an advanced understanding of global clinical trial regulations and practical experience overseeing, preparing for and hosting major regulatory inspections, including those conducted by the FDA, MHRA and BfArM. He has worked across multiple quality functions, including Quality Management System development, implementation and maintenance; audit and compliance activities; root cause analysis; and corrective and preventive action planning.

His specialist areas include building and maintaining robust Quality Management Systems, designing annual audit programmes, conducting vertical, horizontal, directed, routine and for-cause GCP audits, managing GCP vendor audits and oversight, and supporting inspection readiness. This breadth of experience enables him to provide practical, regulation-focused insight into clinical trial quality and compliance.